What is Tenax Therapeutics Inc (TENX) stock price today?

Tenax Therapeutics Inc (TENX) currently trades at $13.11 per share. The stock has a market capitalization of $376.32M and a P/E ratio of —x.

Is TENX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Tenax Therapeutics Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Is Tenax Therapeutics Inc financially healthy?

Tenax Therapeutics Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

TENX

Tenax Therapeutics Inc

NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY

$13.11

+2.58% today

Updated 2026-04-30

Market cap

$376.32M

P/E ratio

—

P/S ratio

414.72x

EPS (TTM)

$-1.34

Dividend yield

—

52W range

$5 – $18

Volume

0.5M

Market cap

$376.32M

P/E ratio

—

P/S ratio

414.72x

EPS (TTM)

$-1.34

Dividend yield

—

52W range

$5 – $18

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.3

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$29.57

+125.55%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-13.41M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-11.05M	$-7.71M	$-17.60M	$-52.60M	$-15.54M
EPS	—	—	—	—	$-1.34
Free cash flow	$-12.02M	$-5.91M	$-14.81M	$-35.80M	$-13.41M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TENX	$376.32M	31	4.3	3.0	5.3	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Tenax Therapeutics Inc trades at $13.11. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Tenax Therapeutics Inc's stock price?

Tenax Therapeutics Inc (TENX) trades at $13.11.

Is Tenax Therapeutics Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Tenax Therapeutics Inc (TENX)?

The analyst target price is $29.57, representing +125.6% upside from the current price of $13.11.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.tenaxthera.com

Quick metrics

P/S ratio414.72x

ROE-55.60%

Beta1.19

50D MA$13.73

200D MA$10.01

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TENX vs LLY →TENX vs JNJ →TENX vs ABBV →Stock screener →